
News|Articles|March 11, 2024
Measuring Speaker Campaign Effectiveness
Author(s)Pharmagin
Sales and marketing effectiveness of speaker programs is often one of the least understood aspects in the industry. Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. CMS’s Open Payments data is an overlooked tool to get greater visibility and create more strategic opportunities—while also enriching compliance. This paper explores how to filter and pinpoint critical data sets using browser-based technology to gain marketing insights from this data and measure competitiveness.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
3
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5